157 related articles for article (PubMed ID: 38326745)
1. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
Li C; Liu H; Duan Z
BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
[TBL] [Abstract][Full Text] [Related]
2. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy.
Meggyes M; Nagy DU; Feik T; Boros A; Polgar B; Szereday L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142692
[No Abstract] [Full Text] [Related]
3. Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia.
Szereday L; Nagy DU; Csiszar B; Kevey D; Feik T; Meggyes M
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829838
[TBL] [Abstract][Full Text] [Related]
4. TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4
Kamrani A; Soltani-Zangbar MS; Shiri S; Yousefzadeh Y; Pourakbari R; Aghebati-Maleki L; Mehdizadeh A; Danaii S; Jadidi-Niaragh F; Yousefi B; Kafil HS; Hojjat-Farsangi M; Motavalli R; Zolfaghari M; Haji-Fatahaliha M; Mahmoodpoor A; Ahmadian Heris J; Emdadi A; Yousefi M
Immunol Invest; 2022 May; 51(4):1023-1038. PubMed ID: 33855917
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
Front Immunol; 2020; 11():1619. PubMed ID: 32793241
[TBL] [Abstract][Full Text] [Related]
6. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
[TBL] [Abstract][Full Text] [Related]
7. Investigation of mucosal-associated invariant T (MAIT) cells expressing immune checkpoint receptors (TIGIT and CD226) in early-onset preeclampsia.
Meggyes M; Nagy DU; Szigeti B; Csiszar B; Sandor B; Tamas P; Szereday L
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():373-381. PubMed ID: 32682212
[TBL] [Abstract][Full Text] [Related]
8. CD226 opposes TIGIT to disrupt Tregs in melanoma.
Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
[TBL] [Abstract][Full Text] [Related]
9. CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells.
Yasutomi M; Christiaansen AF; Imai N; Martin-Orozco N; Forst CV; Chen G; Ueno H
Front Immunol; 2022; 13():840457. PubMed ID: 35273617
[TBL] [Abstract][Full Text] [Related]
10. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
11. CD155/TIGIT, a novel immune checkpoint in human cancers (Review).
Liu L; You X; Han S; Sun Y; Zhang J; Zhang Y
Oncol Rep; 2021 Mar; 45(3):835-845. PubMed ID: 33469677
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Rezaeepoor M; Behzad M
Immunol Lett; 2020 Sep; 225():1-8. PubMed ID: 32540486
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8
Banta KL; Xu X; Chitre AS; Au-Yeung A; Takahashi C; O'Gorman WE; Wu TD; Mittman S; Cubas R; Comps-Agrar L; Fulzele A; Bennett EJ; Grogan JL; Hui E; Chiang EY; Mellman I
Immunity; 2022 Mar; 55(3):512-526.e9. PubMed ID: 35263569
[TBL] [Abstract][Full Text] [Related]
14. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
[TBL] [Abstract][Full Text] [Related]
15. Recovery of CD226-TIGIT
Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
[TBL] [Abstract][Full Text] [Related]
16. Human CD4
Šunina M; Alnek K; Kisand K; Uibo R
Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
[TBL] [Abstract][Full Text] [Related]
17. Decrease in CD226 expression on CD4
Li C; Zhou J; Shao J; Yuan L; Cheng Q; Wang L; Duan Z
Biosci Trends; 2023 May; 17(2):168-171. PubMed ID: 37081668
[TBL] [Abstract][Full Text] [Related]
18. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
[TBL] [Abstract][Full Text] [Related]
19. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies.
Li W; Deng C; Yang H; Tian X; Chen L; Liu Q; Gao C; Lu X; Wang G; Peng Q
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37491355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
